Robert C. Stoler

Jul 26, 2023 | onlinelibrary.wiley.com | David Kandzari |Hector M. Garcia-Garcia |Robert C. Stoler |Baylor Scott

Abstract Background Ultrathin strut coronary drug-eluting stents (DES) have demonstrated improved safety and efficacy in large contemporary trials. The evaluation of an ultrathin strut DES in a post-market United States (US) patient population was undertaken.

Apr 26, 2023 | healio.com | Brian Ellis |Richard Smith |Robert C. Stoler

Source/Disclosures Source: Healio Interviews. Disclosures: Stoler reports proctoring cases and serving on the advisory board for all TAVR valve companies. We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. During the past decade, the options for practitioners of transcatheter aortic valve replacement have expanded on a regular basis.